Focus: ConvaTec is a public medical technology company specializing in wound care, infusion systems, and critical care solutions for chronic conditions including diabetic foot ulcers, venous leg ulcers, and ostomy management. The company operates as a diversified medtech manufacturer with a broad portfolio of devices and accessories rather than traditional pharmaceuticals.
Profile data last refreshed 11h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow ConvaTec to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from ConvaTec's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for ConvaTec
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Explore UK Healthcare Stocks as Patent Wins, Regulatory Clarity and Steady Guidance Lead While FTSE 100 Trades Higher - Kalkine Media
Explore UK Healthcare Stocks as Patent Wins, Regulatory Clarity and Steady Guidance Lead While FTSE 100 Trades Higher Kalkine Media
Can Convatec (LSE:CTEC) Keep Margin Progress On Track While Its Buyback Runs On? - Kalkine Media
Can Convatec (LSE:CTEC) Keep Margin Progress On Track While Its Buyback Runs On? Kalkine Media
ConvaTec stock closes at 209.40 pence, down 1.13 percent at the London close - AD HOC NEWS
ConvaTec stock closes at 209.40 pence, down 1.13 percent at the London close AD HOC NEWS
ConvaTec stock closes at 209.40 pence, down 1.13 percent at the London close - ad-hoc-news.de
ConvaTec stock closes at 209.40 pence, down 1.13 percent at the London close ad-hoc-news.de
Vizient Recognizes Suppliers for Service Excellence - Business Wire
Vizient Recognizes Suppliers for Service Excellence Business Wire
Robert W. Loy Obituary (2026) - New Hope, PA - John F. Givnish Funeral Home - Buckingham - legacy.com
Robert W. Loy Obituary (2026) - New Hope, PA - John F. Givnish Funeral Home - Buckingham legacy.com
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Exudate management with a next-generation multilayered foam dressing in traumatic and surgical wounds: a prospective, multicentre study.
Moisture-Responsive Friction Adaptability: Rethinking the Conventional Skin Silicone Interfaces in Pressure Injury Prevention Dressing Designs.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo